Tag: CSE:PREV
July 9, 2019
PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System
PreveCeutical Successfully Incorporates Medicinal Cannabis Extracts into the Sol-Gel Drug Delivery System June 21, 2019
PreveCeutical Announces Appointment of New Directors
PreveCeutical Medical Inc. (CSE:PREV), is pleased to announce the appointments of Keith Anderson and Mark Lotz to the board of... June 17, 2019
PreveCeutical Announces Further Positive Results from its Dual Gene Therapy Research Program
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical"), is pleased to provide positive results from... June 3, 2019
PreveCeutical Secures $300,000 Loan and Resignation of a Director
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H)(the "Company" or "PreveCeutical") announces that it has received a loan in the aggregate amount... May 21, 2019
PreveCeutical Granted Approval to Acquire and Use Human Mucosal Tissue for Final Phase of Sol-Gel Program
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical"), announces that the Company's research team at the University of... April 17, 2019
PreveCeutical Partnership Leads to Two New Patent Filings
PreveCeutical Medical Inc. (CSE:PREV) (OTCQB PRVCF) (FSE:18H) (the "Company" or "PreveCeutical") announces that the Company's research collaboration with UniQuest and The University of... April 15, 2019